A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
Clinical trial NCT06305351 · COMPLETED
Trial details
- NCT number
- NCT06305351
- Sponsor
- Kallyope Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2024-05-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.